≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Disorders of other and unspecified cranial nerves

DOID EFO Endpoint Browser PheWeb

G6_DISOTHUNS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — G52.8, G52.9
  • Hospital discharge: ICD-9 — 3524|3529
  • Hospital discharge: ICD-8 — 3560[8-9]
  • Cause of death: ICD-10 — G52.8, G52.9
  • Cause of death: ICD-9 — 3524|3529
  • Cause of death: ICD-8 — 3560[8-9]

2 out of 7 registries used, show all original rules.

195

4. Check minimum number of events

None

195

5. Include endpoints

None

195

6. Filter based on genotype QC (FinnGen only)

195

Control definitions (FinnGen only)

Control exclude
G6_NERPLEX

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1570 846 707
Only index persons 1256 694 562
Unadjusted period prevalence (%)
Whole population 0.02 0.02 0.02
Only index persons 0.02 0.03 0.02
Median age at first event (years)
Whole population 52.04 52.68 50.94
Only index persons 49.33 50.00 48.49

-FinnGen-

Key figures

All Female Male
Number of individuals 195 100 95
Unadjusted period prevalence (%) 0.04 0.03 0.04
Median age at first event (years) 47.26 43.03 51.70

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
172
Matched controls
1721
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G52.8
ICD-10 Finland
Disorders of other specified cranial nerves
+∞
72.0
64
*
G52.9
ICD-10 Finland
Cranial nerve disorder, unspecified
+∞
59.9
54
*
35608
ICD-8 Finland
Other diseases of cranial nerves, Alterius nervi
+∞
30.1
28
*
G51.0
ICD-10 Finland
Bell palsy
+∞
18.0
17
*
35609
ICD-8 Finland
Other diseases of cranial nerves, Unspecified
+∞
14.8
14
*
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
+∞
12.6
12
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
7.5
12.6
30
47
3529X
ICD-9 Finland
Disorders of other cranial nerves, Unspecified disorder of cranial nerves
+∞
10.5
10
*
N03AX16
ATC
pregabalin; oral
3.5
10.3
55
203
TAB00
NOMESCO Finland
Lumbar puncture
8.9
9.7
20
25
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
52.7
8.8
10
*
AA1AD
NOMESCO Finland
CT of head and brain
3.0
8.4
55
230
R51.80
ICD-10 Finland
Headache
3.8
8.2
36
112
ACC51
NOMESCO Finland
Release of median nerve
83.4
7.5
8
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
11.6
6.9
12
11
H53.2
ICD-10 Finland
Diplopia
9.3
6.7
13
15
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
7.9
6.6
14
19
N06AA09
ATC
amitriptyline; systemic
3.6
6.5
29
91
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.3
6.3
22
56

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
112
647
2.72
10.61
8.3
5.9
mmol/l
1.2
1.2
1.21
101
579
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
118
700
2.74
10.59
9.8
7.0
mmol/l
1.2
1.2
1.62
104
586
(3019225) pH of Specimen
37
115
3.74
10.50
4.8
4.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
85
453
2.55
9.16
2.5
2.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
65
337
2.39
7.13
2.4
2.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
85
515
2.15
6.27
4.1
3.4
mmol/l
2.4
2.4
0.26
74
452
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
41
181
2.60
6.26
4.2
4.4
%
31.6
32.4
0.14
32
114
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
112
755
2.14
6.25
6.8
6.2
umol/l
10.3
11.2
0.71
107
712
(3013826) Glucose [Moles/volume] in Serum or Plasma
122
851
2.16
6.21
6.8
4.7
mmol/l
6.8
6.6
0.27
116
788
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
99
646
2.08
5.92
4.4
4.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
94
605
2.07
5.80
2.7
2.3
nmol/l
78.8
76.1
0.33
87
531
(3018677) aPTT in Platelet poor plasma by Coagulation assay
45
216
2.41
5.74
3.8
1.7
s
28.9
29.4
0.16
45
210
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
149
1143
2.29
5.72
9.7
7.0
u/l
82.0
77.2
0.42
139
1063
(3019309) Folate [Moles/volume] in Red Blood Cells
52
269
2.27
5.58
1.8
1.7
nmol/l
1038.2
1193.2
0.48
39
205
(3032080) INR in Blood by Coagulation assay
90
579
2.03
5.48
8.7
8.7
inr
1.3
1.3
0.00
18
165
(3044290) Cell count panel - Cerebral spinal fluid
11
23
5.01
5.08
1.5
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
60
346
2.06
4.83
2.6
2.0
mg/l
2.7
3.1
0.64
47
293
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
88
583
1.93
4.75
2.4
1.9
pmol/l
98.6
94.3
0.30
49
278
(3023368) Bacteria identified in Blood by Culture
64
381
2.01
4.71
4.9
4.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
22
81
2.93
4.70
2.0
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
76
481
1.95
4.69
7.4
5.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
23
87
2.86
4.68
1.2
1.2
—
—
—
0
0
(3013512) EKG study
69
426
1.96
4.55
4.8
3.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
35
167
2.34
4.48
2.9
2.9
%
1.8
1.8
0.03
29
150
(3018010) Neutrophils/100 leukocytes in Blood
100
704
1.86
4.38
7.3
5.3
%
58.9
58.0
0.35
88
657
(3002030) Lymphocytes/100 leukocytes in Blood
100
711
1.83
4.18
7.6
5.6
%
25.9
27.1
0.56
88
660
(3006504) Eosinophils/100 leukocytes in Blood
98
693
1.83
4.17
7.5
5.4
%
2.6
2.7
0.29
87
641
(3019069) Monocytes/100 leukocytes in Blood
98
696
1.82
4.09
7.9
5.7
%
9.0
8.7
0.35
87
648
(3019198) Lymphocytes [#/volume] in Blood
103
746
1.81
4.00
7.2
5.4
e9/l
1.7
1.8
1.09
93
670
(3022096) Basophils/100 leukocytes in Blood
94
674
1.76
3.68
7.8
5.5
%
0.6
0.7
0.51
83
626
(3001604) Monocytes [#/volume] in Blood
100
730
1.76
3.68
7.3
5.2
e9/l
0.6
0.6
0.34
86
634
(3003458) Phosphate [Moles/volume] in Serum or Plasma
36
190
2.10
3.60
7.2
5.9
mmol/l
1.0
1.0
0.10
31
172
(3006315) Basophils [#/volume] in Blood
100
734
1.74
3.58
7.5
5.3
e9/l
0.0
0.0
0.31
86
639
(3001122) Ferritin [Mass/volume] in Serum or Plasma
85
598
1.75
3.52
4.1
2.6
ug/l
123.9
117.3
0.14
75
549
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
14
5.91
3.37
1.3
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
101
756
1.70
3.27
7.8
5.5
e9/l
0.2
0.2
0.08
92
673
(3045414) Leukocytes [Presence] in Urine
16
61
2.77
3.22
2.3
1.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
29
147
2.14
3.20
12.0
10.3
mmol/l
1.5
1.1
0.18
22
111
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
39
221
1.96
3.20
2.1
1.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
110
847
1.69
3.17
11.0
9.4
e9/l
4.1
4.1
0.08
93
739
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
39
3.21
3.15
1.7
2.6
u/ml
0.3
0.4
—
6
20
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
64
428
1.74
3.10
3.2
2.9
ng/l
3525.2
1364.1
0.89
55
368
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
16
5.16
3.08
1.3
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
6
8
7.69
3.07
2.0
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
12
6.00
3.05
1.4
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
22
102
2.30
3.00
1.9
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
5
10.21
2.99
1.6
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
53
340
1.77
2.95
1.6
1.6
nmol/l
25.3
21.7
0.61
43
283
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
43
260
1.84
2.90
4.4
3.3
ng/l
56.7
127.3
0.69
37
208
(3023520) Reticulocytes [#/volume] in Blood
23
112
2.19
2.81
2.8
3.2
e9/l
70.2
71.2
0.04
15
94
(3026008) Bacteria identified in Urine by Culture
64
441
1.67
2.73
3.8
3.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
65
450
1.67
2.73
4.7
3.7
ph
7.4
7.4
—
7
87
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
74
2.42
2.66
1.6
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
69
0.00
2.66
0.0
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
29
158
1.98
2.66
4.1
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
125
1022
1.62
2.63
5.9
4.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
18
81
2.35
2.63
1.4
1.2
—
30.4
—
0
9
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
28
152
1.98
2.59
1.9
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
11
5.59
2.56
1.0
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
6
11
5.59
2.56
1.5
1.2
mmol/l
1.6
1.8
—
6
11
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48
311
1.72
2.56
2.1
1.6
mg/l
0.8
1.5
1.29
43
247
(3042936) Bacteria identified in Isolate by Culture
36
216
1.82
2.48
1.9
2.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
27
148
1.96
2.44
1.9
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
12
5.12
2.42
1.5
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
75
554
1.57
2.37
5.1
3.7
ng/l
57.4
36.7
0.63
55
380
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
167
1493
1.83
2.29
23.0
13.7
mg/l
21.6
24.3
0.49
146
1160
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
13
4.72
2.29
1.3
1.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
118
971
1.55
2.26
6.8
4.3
e6/l
11.0
249.3
—
5
22
(3003694) ABO and Rh group [Type] in Blood
55
381
1.62
2.26
1.3
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
9
5.67
2.22
1.4
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
14
4.38
2.16
1.2
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
45
302
1.64
2.08
1.4
1.8
pmol/l
436.9
16194776.4
0.50
39
247
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
37
236
1.70
2.07
4.8
2.5
e6/l
0.8
0.8
0.14
24
121
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
38
2.72
2.04
1.8
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
38
2.72
2.04
4.1
2.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
15
70
2.24
2.04
5.7
2.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
9
32
2.90
2.03
1.4
1.2
e6/l
34.6
95.5
—
9
25
(3020682) Albumin/Creatinine [Ratio] in Urine
61
446
1.54
1.96
4.5
3.6
mg/mmol
15.9
9.8
0.48
43
280
(3011397) Hemoglobin [Presence] in Urine by Test strip
47
324
1.59
1.95
4.8
3.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
36
232
1.68
1.94
5.5
2.8
e6/l
2.0
1.9
0.05
22
118
(40761511) CBC panel - Blood by Automated count
172
1570
1.81
1.94
19.3
12.7
—
—
—
0
0
(3012544) pH of Venous blood
22
122
1.91
1.94
3.6
4.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
127
1084
1.49
1.89
5.4
3.8
mm/h
11.7
12.6
0.33
118
989
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
46
2.47
1.89
1.3
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
60
441
1.52
1.88
4.2
2.8
mmol/l
7.1
7.6
0.43
53
365
(40768804) Tissue Pathology biopsy report
76
587
1.48
1.88
2.7
2.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
17
3.61
1.85
1.2
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
29
2.83
1.81
1.5
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
34
221
1.65
1.78
1.3
1.2
u/ml
1.2
11.4
1.09
12
80
(3015736) pH of Urine
74
574
1.47
1.77
4.4
3.3
—
—
—
0
0
(4024509)
5
13
3.92
1.72
1.4
1.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
19
3.22
1.67
1.3
7.9
—
198.8
—
0
5
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
56
2.22
1.65
2.5
1.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
43
302
1.54
1.64
1.5
1.2
u/ml
6.3
1.4
—
10
89
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
115
980
1.42
1.61
3.8
2.8
u/l
47.4
44.1
0.24
105
913
(3045424) Erythrocytes [Presence] in Urine
7
26
2.75
1.59
1.7
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
20
3.06
1.59
2.7
5.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
35
238
1.57
1.54
1.4
1.3
iu/ml
10.3
37.2
—
10
68
(3002582) Erythrocytes [#/volume] in Urine
62
476
1.44
1.54
5.4
3.0
e6/l
22.2
193.7
0.67
51
359
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
15
3.39
1.53
1.4
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
19
109
1.82
1.53
4.1
2.3
ml/min/173m2
59.8
65.4
—
8
48
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
72
2.02
1.53
1.1
1.0
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
14
72
2.02
1.53
19.5
10.2
%
94.4
94.7
0.09
14
72
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
21
2.91
1.51
1.3
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
21
2.91
1.51
1.3
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
21
2.91
1.51
1.3
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
21
2.91
1.51
1.3
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
21
2.91
1.51
1.3
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
150
1350
1.48
1.50
6.2
4.4
mu/l
1.8
2.0
1.26
136
1204
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
69
543
1.42
1.49
5.3
3.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
156
1417
1.50
1.47
20.0
12.9
ml/min/173m2
81.2
79.8
0.28
131
1145
(3049717) Cytology report of Urine Cyto stain
12
59
2.10
1.47
2.7
2.6
—
—
—
0
0
(4010399)
18
103
1.82
1.46
1.1
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
48
354
1.47
1.46
3.9
2.6
umol/l
372.6
8103.8
1.76
40
295
(3012516) Albumin [Mass/volume] in Urine
55
417
1.44
1.45
4.1
2.9
mg/l
40.4
213.2
0.60
42
274
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
39
2.37
1.45
1.1
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
16
3.18
1.44
1.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
22
2.78
1.44
1.3
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
125
1094
1.40
1.42
5.2
3.7
pmol/l
14.9
14.8
0.21
108
973
(3004588) Protein electrophoresis panel - Serum or Plasma
16
89
1.87
1.42
1.8
2.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
53
2.14
1.41
2.0
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
7
29
2.46
1.40
1.0
1.5
mu/l
202.1
308.5
—
7
29
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
41
2.25
1.39
10.0
1.8
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
26
170
1.61
1.34
13.5
6.4
mmol/l
103.8
104.2
0.14
26
165
(3030467) Casts [#/volume] in Urine by Automated count
55
424
1.41
1.32
4.7
2.9
e6/l
0.4
0.5
0.21
45
302
(36304419) Bacteria [Presence] in Urine
54
415
1.42
1.32
4.8
2.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
34
2.41
1.31
1.3
1.3
—
—
—
0
0
(4035726)
21
131
1.68
1.30
1.0
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
143
0.47
1.26
1.3
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
11
57
1.99
1.19
2.7
2.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
20
2.54
1.16
1.2
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
20
2.54
1.16
1.0
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
7
30
2.38
1.13
4.1
3.7
mmol/l
6.4
7.2
—
7
30
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
7
30
2.38
1.13
1.1
1.2
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
7
31
2.30
1.11
4.1
3.6
mmol/l
1.5
1.4
—
7
31
(3018095) Leukocytes [#/volume] in Urine
68
559
1.33
1.08
6.3
3.6
e6/l
99.2
60.8
0.33
51
385
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
170
1599
1.49
1.06
14.1
9.8
u/l
28.8
25.3
0.92
165
1538
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
11
60
1.88
1.05
3.8
4.0
mmol/l
23.4
24.3
0.25
11
54
(40760892) CBC W Ordered Manual Differential panel - Blood
42
322
1.39
1.03
3.5
4.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
151
1397
1.36
0.99
7.1
5.6
mmol/mol
41.8
39.7
1.28
135
1301
(3022145) Colonoscopy Study observation
23
159
1.51
0.96
1.3
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
25
176
1.48
0.96
1.2
1.3
—
—
—
0
0
(3036489) Thrombin time
9
51
1.80
0.96
2.6
1.5
s
21.3
21.7
—
9
46
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
27
2.26
0.94
1.3
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
27
2.26
0.94
1.3
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
110
1.60
0.94
4.3
3.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
55
1.86
0.94
1.3
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
16
103
1.60
0.90
3.1
2.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
11
64
1.76
0.88
8.4
3.7
mmol/l
25.2
24.8
0.17
11
64
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
19
129
1.52
0.87
3.4
2.5
ug/l
4.2
8.0
0.88
14
113
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
102
906
1.26
0.86
3.4
3.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
175
1669
1.47
0.86
32.7
20.0
e9/l
253.3
246.4
0.75
169
1619
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
32
242
1.39
0.86
1.9
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
31
1.96
0.85
3.3
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
36
279
1.36
0.84
1.7
1.4
g/l
2.3
2.7
0.98
19
177
(3026361) Erythrocytes [#/volume] in Blood
175
1671
1.46
0.83
32.7
19.9
e12/l
4.4
4.5
0.67
168
1616
(3010813) Leukocytes [#/volume] in Blood
175
1671
1.46
0.83
32.7
20.0
e9/l
6.8
6.6
0.47
168
1615
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
32
1.90
0.82
1.2
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
20
141
1.47
0.78
1.9
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
9
53
1.73
0.76
2.1
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
76
1.62
0.73
4.8
3.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
56
1.64
0.73
1.4
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
85
750
1.24
0.73
5.0
3.6
estimate
0.0
0.0
—
8
135
(3021601) Nitrite [Presence] in Urine by Test strip
84
741
1.23
0.72
6.8
4.8
estimate
0.0
0.0
—
7
141
(3035350) Ketones [Presence] in Urine by Test strip
83
732
1.23
0.71
4.9
3.6
estimate
0.0
0.0
—
5
139
(3000494) Fungus identified in Specimen by Culture
23
170
1.40
0.71
1.5
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
26
1.95
0.71
1.6
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
27
1.87
0.69
2.6
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
15
103
1.49
0.67
22.8
8.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
17
120
1.46
0.67
16.3
11.9
g/l
116.4
118.5
0.16
17
115
(40768797) Stomach Pathology biopsy report
25
190
1.36
0.67
1.2
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
28
1.81
0.66
2.8
2.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
10
62
1.65
0.66
6.4
2.5
%
1.3
1.1
—
10
62
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
44
1.61
0.66
1.7
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
79
1.55
0.64
2.3
2.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
14
96
1.49
0.63
1.6
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
47
394
1.25
0.63
10.9
6.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
49
1.66
0.63
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
49
1.66
0.63
1.0
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
49
1.66
0.63
1.4
3.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
50
1.63
0.62
1.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
30
1.68
0.62
1.0
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
30
1.68
0.62
2.0
3.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
22
0.00
0.59
0.0
1.2
—
7.6
—
0
16
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
89
1.49
0.59
1.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
8
124
0.63
0.56
2.6
4.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
37
1.64
0.56
1.8
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
38
1.60
0.55
1.2
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
39
1.56
0.53
1.2
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
21
162
1.33
0.52
6.4
6.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
152
1449
1.22
0.52
4.8
4.4
mmol/l
6.1
5.9
1.13
137
1323
(3019832) Treponema pallidum Ab [Presence] in Serum
8
116
0.68
0.47
1.5
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
35
294
1.23
0.47
2.8
3.1
ug/l
1.0
0.9
0.23
24
192
(3009542) Hematocrit [Volume Fraction] of Blood
144
1371
1.19
0.47
24.7
14.7
%
38.8
40.1
0.94
102
1005
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
57
505
1.18
0.45
5.7
4.9
ug/l
7.8
3.0
0.74
52
458
(3019060) Gas panel - Arterial blood
12
87
1.40
0.43
5.8
9.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
33
1.53
0.41
1.6
1.3
—
—
—
0
0
(4281824)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
0
15
0.00
0.41
0.0
3.1
—
53.0
—
0
5
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
16
0.00
0.41
0.0
1.9
—
32.6
—
0
16
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.4
—
39.5
—
0
5
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
0
18
0.00
0.40
0.0
1.1
—
115.3
—
0
18
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
50
557
0.86
0.36
2.9
2.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
41
1.48
0.36
1.5
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
45
399
1.17
0.35
4.8
4.4
%
24.1
21.6
0.73
32
193
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
156
1509
1.17
0.34
5.4
4.8
mmol/l
2.6
2.7
1.25
141
1383
(1761482) Bacteria [#/volume] in Urine by Culture
6
45
1.34
0.34
5.3
4.3
—
—
—
0
0
(3020891) Body temperature
7
53
1.33
0.31
10.1
3.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
38
426
0.87
0.30
4.3
3.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
62
1.30
0.28
28.3
16.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
147
1425
1.13
0.27
4.5
3.9
mmol/l
1.3
1.3
0.22
132
1303
(3021589) Normoblasts [#/volume] in Blood
71
663
1.11
0.26
9.1
9.0
e9/l
0.0
0.0
0.63
57
544
(3025941) Bacteria identified in Stool by Culture
9
77
1.18
0.24
1.2
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
5
37
1.36
0.23
3.0
2.2
kpa
7.8
8.0
—
5
30
(3027944) Amphetamines [Presence] in Urine
5
41
1.23
0.22
1.6
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
41
1.23
0.22
1.6
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
54
580
0.90
0.22
5.7
3.7
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
10
0.00
0.21
0.0
3.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
80
1.26
0.21
1.0
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
3.9
—
34.4
—
0
13
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
136
1.19
0.21
1.6
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
48
1.26
0.20
1.3
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.3
—
9.0
—
0
14
(3051611) Lipemic interference index of Serum or Plasma
0
14
0.00
0.20
0.0
3.3
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
98.2
—
0
14
(4034850)
6
52
1.16
0.19
3.8
10.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
25
223
1.14
0.19
1.8
2.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
38
410
0.91
0.17
6.0
3.8
estimate
0.0
0.0
—
7
138
(3017181) Myelocytes/100 leukocytes in Blood
14
122
1.16
0.14
2.7
4.8
%
3.8
0.8
—
5
38
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
150
1474
1.08
0.13
4.8
4.3
mmol/l
1.4
1.5
0.45
134
1353
(3021440) Promyelocytes/100 leukocytes in Blood
13
114
1.15
0.12
2.8
5.0
%
0.4
0.1
—
5
32
(3044889) 12 lead EKG panel
102
1047
0.95
0.11
4.2
3.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
16
144
1.12
0.11
2.9
3.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
12
106
1.14
0.10
2.3
4.9
%
2.2
0.5
—
5
27
(1002224) Polysomnography panel
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
150
1481
1.06
0.08
5.0
4.4
mmol/l
4.5
4.6
0.88
136
1372
(3017143) Hepatitis C virus Ab [Presence] in Serum
17
156
1.10
0.08
1.9
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
8
75
1.07
0.07
1.5
1.2
u/ml
361.8
116.9
—
8
67
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
14
128
1.10
0.07
1.6
2.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
91
0.87
0.07
1.3
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
112
1.08
0.03
1.6
2.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
20
193
1.04
0.01
2.0
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
11
111
0.99
0.00
2.9
4.9
%
0.2
0.3
—
5
30
(3003338) MCHC [Mass/volume]
127
1272
1.00
0.00
28.9
17.7
g/l
332.7
332.7
0.02
127
1265
(3000492) Spirometry study
13
132
0.98
0.00
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
132
0.98
0.00
1.7
1.5
—
—
—
0
0
(44813793)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
5
56
0.89
0.00
3.8
12.6
%
1.2
1.4
—
5
51
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
116.3
—
0
6
(3026470) Cobalt [Mass/volume] in Blood
0
6
0.00
0.00
0.0
2.2
—
3.3
—
0
6
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
8.0
—
0
6
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.2
—
6.6
—
0
6
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
67
0.89
0.00
1.5
2.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
7.8
—
0.7
—
0
5
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
9.8
—
6.6
—
0
5
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
22
220
1.00
0.00
1.8
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
18.1
—
0
5
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000012) Reticulocyte production index
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
52
0.96
0.00
1.4
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
54
0.92
0.00
1.4
1.9
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
7
0.00
0.00
0.0
2.1
—
1678.6
—
0
7
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
1.8
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint G6_DISOTHUNS and mortality.

Females

Parameter HR [95% CI] p-value
G6_DISOTHUNS 1.896 [1.51, 2.38] < 0.001
Birth year 0.995 [0.99, 1.0] 0.224

During the follow-up period (1.1.1998 — 31.12.2019), 134 out of 486 females with G6_DISOTHUNS died.

Males

Parameter HR [95% CI] p-value
G6_DISOTHUNS 1.575 [1.2, 2.06] < 0.001
Birth year 0.984 [0.97, 0.99] 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 112 out of 418 males with G6_DISOTHUNS died.

Mortality risk

Mortality risk for people of age

years, who have G6_DISOTHUNS.

N-year risk Females Males
1 0.141% 0.319%
5 1.129% 1.779%
10 2.979% 4.367%
15 5.596% 8.369%
20 9.291% 13.813%

Relationships between endpoints

↥

Index endpoint: G6_DISOTHUNS – Disorders of other and unspecified cranial nerves

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data